The EU-funded ECRAID-Base project is central to the European Clinical Research Alliance for Infectious Diseases (Ecraid), enhancing Europe's defences against emerging infectious diseases (EID) and antimicrobial resistance (AMR). Coordinated by the Ecraid foundation, it establishes a self-sustainable clinical research network. The initial studies include five Perpetual Observational Studies (POS) and the adaptive platform trial REMAP-CAP, generating evidence to advance prevention, diagnosis, and treatment of infectious diseases. This effort ensures a robust response to emerging public health threats.
In collaboration with Ecraid and the European Respiratory Society (ERS), ESCMID is helping ECRAID-Base clinical sites stay at the top of the game by offering regular training and educational opportunities, both online and in-person. This ensures adherence to the OPERATES training criteria: Organised, Prepared, Engaged, Resourced, Active, Trained, Extensive and Sustainable. These opportunities are open to all clinical sites and investigators within the wider Ecraid network and are also often open to unaffiliated but interested people.